RELN and neoplasm: Based on the nucleotide sequences coding the selected peptide (T3) and iRGD peptide, recombinant plasmids were constructed that provided synthesis of fusion proteins T3-RL2, RL-iRGD-His and RL2-iRGD consisting of tumor-specific peptides and cytotoxic protein RL2.